Funds · OCUL

Who owns OCUL?

Institutional ownership of Ocular Therapeutix Inc. from Form 13F, Q2 2026

262 institutional managers reported holding Ocular Therapeutix Inc. (OCUL) in Form 13F filings for Q2 2026, with 207,293,500 shares worth $2.0B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 255,745 shares (+0.1%). 30 opened new positions and 38 sold out.

Funds holding
262
Value held
$2.0B
New / sold out
30 / 38
Net shares, same filers
+0.1%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of OCUL

FundValueShare of 13F holdingsSharesMove
FMR LLC$323M15.8%32,844,043Added
Deep Track Capital, LP$193M9.5%19,686,282Unchanged
BlackRock, Inc.$190M9.3%19,376,555Added
Avoro Capital Advisors LLC$123M6.0%12,540,000Added
Summer Road LLC$120M5.9%12,208,296Added
Venrock Adviser, LLC$102M5.0%10,346,926Unchanged
Vanguard Capital Management LLC$86.7M4.3%8,832,595Added
Price T Rowe Associates Inc$74.9M3.7%7,623,533Added
Logos Global Management LP$52.0M2.6%5,300,000Added
State Street Corp$51.4M2.5%5,233,282Added
Geode Capital Management, LLC$49.3M2.4%5,021,092Added
Point72 Asset Management, L.P.$32.3M1.6%3,292,193Trimmed
Dimensional Fund Advisors LP$27.3M1.3%2,783,367Added
Deltec Asset Management LLC$24.3M1.2%2,476,197Added
Balyasny Asset Management L.P.$22.3M1.1%2,270,707Trimmed
Octagon Capital Advisors LP$20.4M1.0%2,075,000Trimmed
Vanguard Portfolio Management LLC$19.4M1.0%1,973,130Added
Northern Trust Corp$17.7M0.9%1,799,426Added
Goldman Sachs Group Inc$17.3M0.8%1,761,754Added
Nuveen, LLC$16.7M0.8%1,697,274Added
Woodline Partners LP$16.4M0.8%1,667,609Unchanged
TCG Crossover Management, LLC$16.2M0.8%1,647,752Unchanged
UBS Group AG$15.2M0.7%1,551,001Added
Adage Capital Partners GP, L.l.c.$15.2M0.7%1,550,000New
Charles Schwab Investment Management Inc$15.1M0.7%1,533,438Added

Share of 13F holdings is each fund's shares as a share of the 207,293,500 OCUL shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $220M and sold $203M; 105 added and 78 trimmed.

Schedule 13D and 13G filings on OCUL

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about OCUL ownership

Who owns OCUL stock?
262 institutional investment managers reported OCUL positions in their Form 13F filings for Q2 2026, holding 207,293,500 shares worth $2.0B in total. FMR LLC reported the largest position.
Are funds buying or selling OCUL?
In Q2 2026, 30 managers opened new OCUL positions, 105 added, 78 trimmed and 38 sold out. Managers that filed in both quarters added a net 255,745 shares.
How current is this OCUL institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to OCUL by CUSIP. Options are left out. OCUL news and filings · OCUL insider trades · Top funds